课题基金 / 基金详情

In vivo quantification of tau aggregates as a measure of disease progression in Alzheimer's disease spectrum

In vivo quantification of tau aggregates as a measure of disease progression in Alzheimer's disease spectrum
tau 聚集体的体内定量作为阿尔茨海默病谱系疾病进展的衡量标准
批准号：
455792
负责人：
Rosa-Neto Pedro
金额：
$7.29万
依托单位：
CIUSSS de l'Ouest-de-l'Ile-de-Montral-Douglas Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=455792&lang=en
关键词：
Alzheimer'S Disease Fluid Biomarkers Imaging Pet Amyloid Pet Tau

项目摘要

项目成果

Rosa-Neto Pedro的其他基金

相似基金

相关文献

中文摘要
翻译
阿尔茨海默病(AD)是一种不可逆转的进行性大脑疾病，会影响记忆和智力技能。患有阿尔茨海默病的人最终会失去自主性，无法执行最简单的任务。AD最常见的形式是t
英文摘要
Alzheimer's disease (AD) is an irreversible, progressive brain condition that affects memory and intellectual skills. People suffering from AD eventually lose their autonomy and are not able to carry out the simplest tasks. The most common form of AD is t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex differences in brain tau aggregates.
In vivo quantification of tau aggregates as a measure of disease progression in Alzheimer's disease spectrum
Imaging epigenetics in dementia
Interactions between pathophysiological processes as drivers of clinical progression in Alzheimer's disease
海外基金